The Vietnamese pharmaceutical market: a comparison of foreign entry strategies

Daniel Simonet

International Journal of Business and Emerging Markets, 2008, vol. 1, issue 1, 61-79

Abstract: Background. Entry strategies in the Vietnamese pharmaceutical market are under-researched. Aim. The first part of the paper provides an overview of the Vietnamese pharmaceutical market, and the second part a theoretical framework to understand the various foreign entry strategies. Methodology. Literature review and interviews with professionals. Contribution. Preference for one mode over another depends on market and company characteristics, the firm's objectives and risk aversion level. Recommendations. There are few joint ventures. Licensing and acquisition of a local drug firm appear risky owing to lack of IP rights and cultural clash. The long-term pay-offs of wholly owned subsidiaries are higher.

Keywords: pharmaceutical drugs; Vietnam; market entry strategy; joint ventures; emerging markets; foreign entry strategies; pharmaceutical market. (search for similar items in EconPapers)
Date: 2008
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.inderscience.com/link.php?id=19245 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ids:ijbema:v:1:y:2008:i:1:p:61-79

Access Statistics for this article

More articles in International Journal of Business and Emerging Markets from Inderscience Enterprises Ltd
Bibliographic data for series maintained by Sarah Parker ().